VitaNova Life Sciences Corp
VNOV· OTC
VNOVVitaNova Life Sciences Corp
Quarterly figures for VitaNova Life Sciences Corp, with source filings when available.
38 quarters. Apr 30, 2017 to Jul 31, 2026. USD.
VitaNova Life Sciences Corp has filed its 10-Q within 40 to 45 days of period end across its last 8 quarters. The 10-K runs 15 to 97 days.
VitaNova Life Sciences Corp · CIK 1699709 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2027 | |||||||||
| Q1 2027 | Jul 31, 2026 | — | Sep 14, 2026 | 45 d | 10-Q | $321.58K | +209.5% | — | |
| FY 2026 | |||||||||
| Q4 2026derived | Apr 30, 2026 | — | Jul 29, 2026 | 90 d | 10-K | $1.78M | −8.6% | — | |
| Q3 2026 | Jan 31, 2026 | — | Mar 16, 2026 | 44 d | 10-Q | $709.63K | +130.2% | -$0.01 | |
| Q2 2026 | Oct 31, 2025 | — | Dec 15, 2025 | 45 d | 10-Q | $427.12K | +46.2% | $0.00 | |
| Q1 2026 | Jul 31, 2025 | — | Sep 12, 2025 | 43 d | 10-Q | $103.90K | −4.2% | $0.00 | |
| FY 2025 | |||||||||
| Q4 2025derived | Apr 30, 2025 | — | Jul 24, 2025 | 85 d | 10-K | $1.95M | +258.7% | — | |
| Q3 2025 | Jan 31, 2025 | — | Mar 17, 2025 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Apr 30, 2024 | — | Jul 29, 2024 | 90 d | 10-K | $544.59K | +18,053.1% | — | |
| Q3 2024 | Jan 31, 2024 | — | Mar 11, 2024 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Apr 30, 2023 | — | May 15, 2023 | 15 d | 10-K | $3.00K | −93.3% | — | |
| Q3 2023 | Jan 31, 2023 | — | Feb 16, 2023 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Apr 30, 2022 | — | May 16, 2022 | 16 d | 10-K | $45.00K | — | — | |
| Q3 2022 | Jan 31, 2022 | — | Feb 17, 2022 | ||||||
| FY 2021 | |||||||||
| Q4 2021derived | Apr 30, 2021 | — | Jul 1, 2021 | 62 d | 10-K | $0.00 | — | — | |
| Q3 2021 | Jan 31, 2021 | — | Jun 21, 2021 | ||||||
| FY 2020 | |||||||||
| Q4 2020derived | Apr 30, 2020 | — | Aug 5, 2020 | 97 d | 10-K | $0.00 | — | — | |
| Q3 2020 | Jan 31, 2020 | — | Mar 20, 2020 | ||||||
| FY 2019 | |||||||||
| Q4 2019derived | Apr 30, 2019 | — | Jul 30, 2019 | 91 d | 10-K | $0.00 | — | — | |
| Q3 2019 | Jan 31, 2019 | — | Mar 15, 2019 | ||||||
| FY 2018 | |||||||||
| Q4 2018derived | Apr 30, 2018 | — | Jul 17, 2018 | 78 d | 10-K | — | — | — | |
| Q3 2018 | Jan 31, 2018 | — | Feb 22, 2018 | 22 d | 10-Q | ||||
| FY 2017 | |||||||||
| Q4 2017 | Apr 30, 2017 | — | — | — | — | — | — | — | |
| 45 d |
| 10-Q |
| $308.32K |
| +1,081.3% |
| $0.01 |
| Q2 2025 | Oct 31, 2024 | — | Dec 13, 2024 | 43 d | 10-Q | $292.12K | — | $0.00 |
|---|
| Q1 2025 | Jul 31, 2024 | — | Sep 10, 2024 | 41 d | 10-Q | $108.48K | — | $0.00 |
|---|
| 40 d |
| 10-Q |
| $26.10K |
| +161.0% |
| $0.00 |
| Q2 2024 | Oct 31, 2023 | — | Dec 15, 2023 | 45 d | 10-Q | $0.00 | −100.0% | $0.00 |
|---|
| Q1 2024 | Jul 31, 2023 | — | Sep 14, 2023 | 45 d | 10-Q | $0.00 | −100.0% | $0.00 |
|---|
| 16 d |
| 10-Q |
| $10.00K |
| −66.7% |
| $0.00 |
| Q2 2023 | Oct 31, 2022 | — | Nov 14, 2022 | 14 d | 10-Q | $10.00K | −77.8% | $0.00 |
|---|
| Q1 2023 | Jul 31, 2022 | — | Sep 1, 2022 | 32 d | 10-Q | $15.00K | — | $0.00 |
|---|
| 17 d |
| 10-Q |
| $30.00K |
| — |
| $0.00 |
| Q2 2022 | Oct 31, 2021 | — | Nov 10, 2021 | 10 d | 10-Q | $45.00K | — | $0.00 |
|---|
| Q1 2022 | Jul 31, 2021 | — | Aug 20, 2021 | 20 d | 10-Q | $0.00 | — | $0.02 |
|---|
| 141 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2021 | Oct 31, 2020 | — | Nov 25, 2020 | 25 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2021 | Jul 31, 2020 | — | Sep 18, 2020 | 49 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 49 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2020 | Oct 31, 2019 | — | Dec 6, 2019 | 36 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2020 | Jul 31, 2019 | — | Sep 12, 2019 | 43 d | 10-Q | $0.00 | — | $0.00 |
|---|
| 43 d |
| 10-Q |
| $0.00 |
| — |
| — |
| Q2 2019 | Oct 31, 2018 | — | Dec 14, 2018 | 44 d | 10-Q | — | — | — |
|---|
| Q1 2019 | Jul 31, 2018 | — | Aug 17, 2018 | 17 d | 10-Q | $0.00 | −100.0% | $0.00 |
|---|
| $0.00 |
| — |
| $0.00 |
| Q2 2018 | Oct 31, 2017 | — | Nov 30, 2017 | 30 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2018 | Jul 31, 2017 | — | — | — | — | $18.40K | — | $0.00 |
|---|
